Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FG3LZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,733
Award facts
- Contract value 100% obligated
- $21,733.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $21,733.30 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injections (0.5 mL units). This firm fixed-price delivery order, issued on January 16, 2026, with an ultimate completion date of January 20, 2026, represents a competitively awarded non-set-aside contract executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems. The contract will be performed at the company's Conshohocken facility.
This delivery order falls under AmerisourceBergen's parent company Cencora, Inc.'s comprehensive $999,999,999.00 IDC with DLA Troop Support Medical extending through December 2031. The IDC serves as a global pharmaceutical support vehicle enabling the supply of an extensive range of medical commodities including specialty medications, brand-name and generic drugs, and vaccines to support military healthcare programs worldwide. Zepbound, a GLP-1 receptor agonist used for weight management, represents the type of specialty pharmaceutical product routinely procured through this vehicle to support the healthcare needs of the Defense Health Agency and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FG3LZ?
SPE2DR26FG3LZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26FG3LZ worth?
The government has obligated $21,733 on SPE2DR26FG3LZ.
Is contract SPE2DR26FG3LZ an order under another contract?
Yes. SPE2DR26FG3LZ is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG3LZ competed?
The extent of competition for SPE2DR26FG3LZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award